Dapagliflozin associated to sacubitril/valsartan exerts additive cardioprotection during exposure to doxorubicin and trastuzumab through improvement of mytogenesis and reduction of MyD88/NLRP3
Pulmonary hypertension in connective tissue diseases with overt of features of venous/capillaries involvement: clinical implications and prognostic impact of this phenotype.